Category: Imaging & mpMRI

When something is described as cost-effective, what does that mean? According to the Merriam Webster Dictionary, it indicates the thing or action produces good results without costing a lot of money. There is no question that multiparametric MRI (mpMRI) of the prostate, performed on a high-power 3T magnet, produces good results. In fact, when interpreted keep reading

Six years ago, we posted a blog about the PROMIS study, which delivered a one-two punch to conventional TRUS biopsies. That blog described a planned follow-on British study that would combine mpMRI with diagnostic biomarkers, in hopes of identifying men whose prostate cancer is so low-risk as to avoid a needle biopsy, and who can be safely monitored. To launch the study... keep reading

Once upon a fairly recent time, radical prostatectomy (RP) was the treatment of choice for prostate cancer (PCa), even for high risk disease. There were two main reasons for this: It was believed that PCa was a multifocal disease scattered throughout the gland, even if too small to be picked up by biopsy. Therefore, aggressively keep reading

Everyone who wants to go through a prostate biopsy, raise your hand. What, no takers? Not surprising. Conventional transrectal ultrasound (TRUS) biopsies commonly involve 12-14 needles, and sometimes as many as 24 in a “saturation” biopsy. TRUS biopsies frequently involve pain and risk of infection. There can be side effects like bleeding and even erectile keep reading

The Radiological Society of North America (RSNA) was founded in 1915. It now has over 54,000 members. There are not only radiologists, but also other medical professionals and even medical physicists. At its annual gathering, its huge attendance makes it one of the largest medical conferences in the world... keep reading

No one wants to go through an invasive clinical procedure if they don’t need it. Who wouldn’t prefer to be spared from simple invasions like blood draws or enemas, let alone major surgeries like replacing a heart valve or removing a lung? From the viewpoint of an individual, we’d like to avoid these if we keep reading

“It has been suggested by some investigators that a negative or stable MRI could replace the surveillance biopsy in men on AS.” – Dr. Badar Mian With apologies to Ralph Waldo Emerson for paraphrasing a famous saying attributed to him: Build a better prostate biopsy and the urological world will beat a path to your keep reading

From conferences to global summits and industry exhibitions, Dubai provides a dynamic business events offering, made up of global connectivity, state-of-the-art hotels and venues, first-class infrastructure and great hospitality. This is how one event site describes the merits of hosting an important international professional conference in the capital city of the emirate of Dubai. In keep reading

I’ve said it before, and I’ll undoubtedly say it again: multiparametric MRI (mpMRI) can avoid unnecessary biopsies. In a previous blog, “A PROMIS is a Promise for Multiparametric MRI,” I cited the results of the PROMIS study in which 576 men initially had an mpMRI scan, then underwent 2 types of needle biopsy (ouch!) so keep reading

If you are diagnosed with prostate cancer (PCa), you want to know, with as much accuracy as possible: PSA and its variants – determined by blood test Gleason score/Gleason Grade Group – determined by biopsy Clinical stage – determined the old-fashioned way by combination of digital rectal exam or DRE, biopsy, inadequate information from ultrasound, keep reading